Nutrients | Free Full-Text | Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review
Metabolites | Free Full-Text | A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population - AJPM Focus
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports
The Effect of Inflammation and Infection on Lipids and Lipoproteins - Endotext - NCBI Bookshelf
Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n-Dimensions (SHY-n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection | Analytical Chemistry
Association of triglycerides to high-density lipoprotein cholesterol ratio with incident cardiovascular disease but not end-stage kidney disease among patients with biopsy-proven diabetic nephropathy | Hypertension Research
Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes – topic of research paper in Health sciences. Download scholarly article PDF and read for
PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. | Semantic Scholar
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study | Scientific Reports
Association of LDL:HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults | Lipids in Health and Disease | Full Text
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease | Journal of the American College of Cardiology
Frontiers | Dyslipidemia in rheumatoid arthritis: the possible mechanisms
Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease? - Martin B Whyte, 2019
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease | Current Atherosclerosis Reports
Immunologic profile and surrogate markers of subclinical... | Download Scientific Diagram
HDL and cardiovascular disease - The Lancet
(PDF) ASSESSMENT OF CARDIOVASCULAR RISK INDICES IN TYPE 2 DIABETES MELLITUS | MATTHEW E ADU - Academia.edu
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study - The Lancet
Effect of Diabetes Medications on Cardiovascular Risk and Surrogate Markers in Patients with Type 2 Diabetes | Semantic Scholar
Frontiers | Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
e Overall approach to lipid-lowering therapy for prevention of... | Download Scientific Diagram
The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study [PeerJ]
There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5 | Scientific Reports
Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease | Arteriosclerosis, Thrombosis, and Vascular Biology